BRCA2 KO Lines for Drug Discovery

Case ID:
C05188

C05188: BRCA2 KO Lines for Drug Discovery


Technical Details:

BRACA2 is a DNA repair gene. Mutations in BRACA2 cause an inherited risk of breast, ovarian and pancreatic cancers. The cancer cell lines are engineered to lack BRACA2 and are useful screening tools for chemotherapeutic or chemopreventative agents

Looking for Partners:

The BRACA2 KO cell line is a useful screening tools for chemotherapeutic or chemopreventative agents.



Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Sahil Aggarwal
sahil.aggarwal@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum